Patents by Inventor Ludivine Petit

Ludivine Petit has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20210290636
    Abstract: The present invention relates to a new use of tetrahydroxylated estrogens such as estetrol (1,3,5(10)-estratrien-3, 15?, 16?, 17?-tetrol), namely in a method of emergency contraception. The method of emergency contraception according to the invention comprises the oral administration of estetrol in a single dose within 120 hours of sexual intercourse.
    Type: Application
    Filed: February 24, 2021
    Publication date: September 23, 2021
    Inventors: Wout Wouters, Herman Jan Tijmen Coelingh Bennink, Ludivine Petit, Jean-Michel Foidart
  • Publication number: 20170196886
    Abstract: The present invention relates to a new use of tetrahydroxylated estrogens such as estetrol (1,3,5(10)-estratrien-3, 15?, 16?, 17?-tetrol), namely in a method of emergency contraception. The method of emergency contraception according to the invention comprises the oral administration of estetrol in a single dose within 120 hours of sexual intercourse.
    Type: Application
    Filed: January 13, 2017
    Publication date: July 13, 2017
    Inventors: Wout Wouters, Herman Jan Tijmen Coelingh Bennink, Ludivine Petit, Jean-Michel Foidart
  • Patent number: 9579329
    Abstract: The present invention relates to a new use of tetrahydroxylated estrogens such as estetrol (1,3,5(10)-estratrien-3, 15?, 16?, 17?-tetrol), namely in a method of emergency contraception. The method of emergency contraception according to the invention comprises the oral administration of estetrol in a single dose within 120 hours of sexual intercourse.
    Type: Grant
    Filed: August 9, 2012
    Date of Patent: February 28, 2017
    Assignee: Estetra S.P.R.L.
    Inventors: Wout Wouters, Herman Jan Tijmen Coelingh Bennink, Ludivine Petit, Jean-Michel Foidart
  • Publication number: 20140200202
    Abstract: The present invention relates to a new use of tetrahydroxylated estrogens such as estetrol (1,3,5(10)-estratrien-3,15?,16?,17?-tetrol), namely in a method of emergency contraception. The method of emergency contraception according to the invention comprises the oral administration of estetrol in a single dose within 120 hours of sexual intercourse.
    Type: Application
    Filed: August 9, 2012
    Publication date: July 17, 2014
    Applicant: Estetra S.P.R.L.
    Inventors: Wout Wouters, Herman Jan Tijmen Coelingh Bennink, Ludivine Petit, Jean-Michel Foidart